Medpace reduces credit line to $10M; Q2 2025 earnings announced, figures not provided

Medpace Holdings, Inc.

Amendment No. 9 to credit facility reduces line of credit to $10M, executed July 17, 2025.
Press release for Q2 2025 and H1 2025 results issued July 21, 2025, but exhibit not included in filing.
Specific financial metrics (revenue, EPS, segment data) unavailable from this filing; confidence low.
No guidance or material operational details disclosed in the 8-K filing body.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.